BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 22527202)

  • 1. Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness.
    Thambiah S; Roplekar R; Manghat P; Fogelman I; Fraser WD; Goldsmith D; Hampson G
    Calcif Tissue Int; 2012 Jun; 90(6):473-80. PubMed ID: 22527202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women.
    Hampson G; Edwards S; Conroy S; Blake GM; Fogelman I; Frost ML
    Bone; 2013 Sep; 56(1):42-7. PubMed ID: 23702386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD.
    Behets GJ; Viaene L; Meijers B; Blocki F; Brandenburg VM; Verhulst A; D'Haese PC; Evenepoel P
    PLoS One; 2017; 12(5):e0176411. PubMed ID: 28493902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD).
    Manghat P; Souleimanova I; Cheung J; Wierzbicki AS; Harrington DJ; Shearer MJ; Chowienczyk P; Fogelman I; Nerlander M; Goldsmith D; Hampson G
    Bone; 2011 May; 48(5):1127-32. PubMed ID: 21281749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclerostin and DKK1 in primary hyperparathyroidism.
    Viapiana O; Fracassi E; Troplini S; Idolazzi L; Rossini M; Adami S; Gatti D
    Calcif Tissue Int; 2013 Apr; 92(4):324-9. PubMed ID: 23430197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating sclerostin and dickkopf-1 levels in ossification of the posterior longitudinal ligament of the spine.
    Kashii M; Matuso Y; Sugiura T; Fujimori T; Nagamoto Y; Makino T; Kaito T; Ebina K; Iwasaki M; Yoshikawa H
    J Bone Miner Metab; 2016 May; 34(3):315-24. PubMed ID: 26040409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Sclerostin as an Independent Marker of Peripheral Arterial Stiffness in Renal Transplantation Recipients: A Cross-Sectional Study.
    Hsu BG; Liou HH; Lee CJ; Chen YC; Ho GJ; Lee MC
    Medicine (Baltimore); 2016 Apr; 95(15):e3300. PubMed ID: 27082570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications.
    Morena M; Jaussent I; Dupuy AM; Bargnoux AS; Kuster N; Chenine L; Leray-Moragues H; Klouche K; Vernhet H; Canaud B; Cristol JP
    Nephrol Dial Transplant; 2015 Aug; 30(8):1345-56. PubMed ID: 25854266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density.
    Voskaridou E; Christoulas D; Plata E; Bratengeier C; Anastasilakis AD; Komninaka V; Kaliontzi D; Gkotzamanidou M; Polyzos SA; Dimopoulou M; Terpos E
    Horm Metab Res; 2012 Nov; 44(12):909-13. PubMed ID: 22581647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnover.
    Gifre L; Ruiz-Gaspà S; Monegal A; Nomdedeu B; Filella X; Guañabens N; Peris P
    Bone; 2013 Nov; 57(1):272-6. PubMed ID: 23981659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Levels of Dickkopf-Related Protein 1 Decrease as Measured GFR Declines and Are Associated with PTH Levels.
    Forster CM; White CA; Turner ME; Norman PA; Ward EC; Hopman WM; Adams MA; Holden RM
    Am J Nephrol; 2020; 51(11):871-880. PubMed ID: 33238271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease.
    Toussaint ND; Lau KK; Strauss BJ; Polkinghorne KR; Kerr PG
    Nephrol Dial Transplant; 2008 Feb; 23(2):586-93. PubMed ID: 17933842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerostin and DKK1: new players in renal bone and vascular disease.
    Evenepoel P; D'Haese P; Brandenburg V
    Kidney Int; 2015 Aug; 88(2):235-40. PubMed ID: 26083653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sclerostin: Another vascular calcification inhibitor?
    Claes KJ; Viaene L; Heye S; Meijers B; d'Haese P; Evenepoel P
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3221-8. PubMed ID: 23788689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients.
    Cejka D; Jäger-Lansky A; Kieweg H; Weber M; Bieglmayer C; Haider DG; Diarra D; Patsch JM; Kainberger F; Bohle B; Haas M
    Nephrol Dial Transplant; 2012 Jan; 27(1):226-30. PubMed ID: 21613383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis.
    Rossini M; Viapiana O; Idolazzi L; Ghellere F; Fracassi E; Troplini S; Povino MR; Kunnathully V; Adami S; Gatti D
    Calcif Tissue Int; 2016 May; 98(5):438-45. PubMed ID: 26645432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of association of LRP5, LRP6, SOST, DKK1, and CTNNB1 genes with bone mineral density in a Slovenian population.
    Mencej-Bedrac S; Prezelj J; Kocjan T; Komadina R; Marc J
    Calcif Tissue Int; 2009 Dec; 85(6):501-6. PubMed ID: 19898734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between markers of collagen turnover, arterial stiffness and left ventricular hypertrophy in chronic kidney disease (CKD): the Renal Research Institute (RRI)-CKD study.
    Dellegrottaglie S; Sands RL; Gillespie BW; Gnanasekaran G; Zannad F; Sengstock D; Finkelstein F; Kiser M; Eisele G; Hinderliter AL; Levin NW; Cattan V; Saran R; Rajagopalan S
    Nephrol Dial Transplant; 2011 Sep; 26(9):2891-8. PubMed ID: 21562144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between sclerostin and Dickkopf-1 with aortic arterial stiffness in patients with type 2 diabetes: A prospective, cross-sectional study.
    Yang HY; Wu DA; Chen MC; Hsu BG
    Diab Vasc Dis Res; 2019 May; 16(3):281-288. PubMed ID: 30547685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disturbances of Wnt/β-catenin pathway and energy metabolism in early CKD: effect of phosphate binders.
    de Oliveira RB; Graciolli FG; dos Reis LM; Cancela AL; Cuppari L; Canziani ME; Carvalho AB; Jorgetti V; Moysés RM
    Nephrol Dial Transplant; 2013 Oct; 28(10):2510-7. PubMed ID: 23975746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.